9/29/2011 3:29 pm
Date / Time filed with the Register of Regulations 		VA.R. Document Number: R____-______
Virginia Register Publication Information

Transmittal Sheet: Response to Petition for Rulemaking
Initial Agency Notice
X
Agency Decision
Promulgating Board: Board of Pharmacy
Regulatory Coordinator: Caroline Juran, RPh

(804)367-4416

caroline.juran@dhp.virginia.gov
Agency Contact: Elaine J. Yeatts

Agency Regulatory Coordinator

()-

elaine.yeatts@dhp.virginia.gov
Contact Address: Department of Health Professions

9960 Mayland Drive, Suite 300

Richmond, VA 23233
Chapter Affected:
18 vac 110 - 20: Virginia Board of Pharmacy Regulations
Statutory Authority: State: Chapters 33 and 34 of Title 54.1

Federal:
Date Petition Received 05/27/2011
Petitioner Karen Dunavant, Courtney Fuller and Annette Reichenbaugh
 Petitioner's Request
Amend requirement for monthly inspection of automated dispensing devices by pharmacy personnel to verify proper storage, location of drugs, expiration dates, drug security and validity of access codes.
 Agency Plan
The Board will publish the petitions on June 20, 2011 and request 21 days of public comment ending July 11, 2011.  The Board will consider the petitions and comments received at its meeting on September 22, 2011 to determine whether to initiate a regulatory action.
Publication Date 06/20/2011  (comment period will also begin on this date)
Comment End Date 07/11/2011
 Agency Decision
Initiate a regulatory change
Agency Response Date 09/29/2011
 Agency Decision Text
The Board of Pharmacy received three petitions for rulemaking from hospital pharmacists requesting an amendment to #5 of section 490 in Chapter 20, which provides requirements for automated devices for dispensing and administration of drugs. The petitioners requested less burdensome requirements for verification of storage, location, expiration dates, drug security and validity of access codes. While the Board agreed that the petition was reasonable and the specific requirements in #5 may need to be modified for consistency with current technology, it concluded that all of section 490 should be examined for possible amendments that would ensure drug security and integrity but would make compliance less burdensome.